In nearly every trade secret misappropriation cases, two fundamental issues must be resolved: (1) Are the alleged trade secrets actually trade secrets under the definition provided in the applicable statute, and (2) has the defendant misappropriated them? See, e.g., Defend Trade Secrets Act (“DTSA”), 18 U.S.C. §§ 1836,1839. Neither issue can be definitively resolved until plaintiff identifies the trade secrets at issue. Thus, in managing case flow and judicial efficiency, a question courts have long grappled with—and continue to grapple with—is when must a plaintiff disclose its alleged trade secrets? Courts across the country have shown mixed approaches. Some have explicit and rigid timing requirements, and some are ambiguous, even allowing a plaintiff to disclose its trade secrets as late as during trial in certain cases.
The issue of trade secret disclosure comes up during two key early stages of litigation: pleadings and discovery. Relevant exemplary decisions and disclosure rules by jurisdiction are highlighted below.
Pleadings Stage
Most courts require a plaintiff to disclose alleged trade secrets in the pleadings stage only insofar as to meet general pleading standards. See, e.g., True Velocity Ammunitions, LLC & Lone Star Future Weapons, Inc. v. Sig Sauer, Inc., No. 2:24-CV-522, 2024 WL 4583118, at *10 (D. Vt. Oct. 25, 2024); Lupin Atlantis Holdings SA v. Xian-Ming Zeng, No. 23-61621-CIV, 2024 WL 4491993, at *3 (S.D. Fla. Oct. 15, 2024); Carlisle Interconnect Techs. Inc. v. Foresight Finishing LLC, No. CV-22-00717-PHX-SPL, 2023 WL 2528324 (D. Ariz. Mar. 15, 2023); Medtech Prods., Inc. v. Ranir, LLC, 596 F. Supp. 2d 778, 789 (S.D.N.Y. 2008). It would be uncommon for a court to mandate specific disclosure of trade secrets in a public complaint—indeed, no cases were readily found requiring such disclosure at the pleadings stage. Courts, on the contrary, frequently permit plaintiffs to identify alleged trade secrets broadly and categorically in pleadings. See, e.g., Beluca Ventures LLC v. Einride Aktiebolag, No. 21-CV-06992-WHO, 2023 WL 2456716, (N.D. Cal. Mar. 10, 2023); cf. Iqvia, Inc. v. Erica Breskin, No. CV 22-2610, 2023 WL 2588450 (E.D. Pa. Mar. 20, 2023). Plaintiffs must articulate their alleged trade secrets with greater particularity at a later point in litigation, almost always after the court has entered a protective order to maintain the secrecy of such disclosure.